Overall Status

Completed (3)

Recruiting (1)

Phase

phase 1 (1)

Sponsor

University of California, San Francisco (3)

Washington University School of Medicine (1)

Collaborator

Tau Consortium (3)

Association of Frontotemporal Degeneration (1)

CBD Solutions (1)

National Center for Advancing Translational Science (NCATS) (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

National Institute on Aging (NIA) (1)

National Institutes of Health (NIH) (1)

The Bluefield Project to Cure Frontotemporal Dementia (1)

Intervention

13c6 leucine (1)

observational study (1)

placebo (1)

tpi 287 2 mg/m2 (1)

tpi-287 20 mg/m2 (1)

tpi-287 6.3 mg/m2 (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (4)

Study Type

Observational (3)

Interventional (1)

corticobasal degeneration (cbd)

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Human CNS Tau Kinetics in Tauopathies

Completed

Progressive Supranuclear Palsy (PSP)
+2 more

13C6 Leucine

Saint Louis, Missouri

Washington University in St. Louis School of Medicine

Apr 12, 2022

Frontotemporal Lobar Degeneration (ARTFL)

Completed

FTLD
+11 more

Birmingham, Alabama
+16 more

May 18, 2021

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

Recruiting

Corticobasal Degeneration (CBD)
+5 more

Observational Study

San Diego, California
+7 more

May 18, 2021

Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP) Trial in Birmingham,

Completed

Primary Four Repeat Tauopathies (4RT)
+3 more

TPI 287 2 mg/m2
+3 more

Birmingham, Alabama
+1 more

Apr 13, 2020